Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs as Potential Biomarkers in Pituitary Adenomas. | Noncoding RNA | 2021 | 34564317 | PubTator, text mining | PubMed |
| PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression. | Sci Rep | 2021 | 34561473 | PubTator, text mining | PubMed |
| clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. | Innovation (Camb) | 2021 | 34557778 | PubTator, text mining | PubMed |
| Multi-View Spectral Clustering Based on Multi-Smooth Representation Fusion for Cancer Subtype Prediction. | Front Genet | 2021 | 34552619 | PubTator, text mining | PubMed |
| NS398 as a potential drug for autosomal-dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models. | J Cell Mol Med | 2021 | 34551202 | PubTator, text mining | PubMed |
| Identification of Key Genes Associated With the Process of Hepatitis B Inflammation and Cancer Transformation by Integrated Bioinformatics Analysis. | Front Genet | 2021 | 34539726 | PubTator, text mining | PubMed |
| Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma. | Front Immunol | 2021 | 34539658 | PubTator, text mining | PubMed |
| Determination of a six-gene prognostic model for cervical cancer based on WGCNA combined with LASSO and Cox-PH analysis. | World J Surg Oncol | 2021 | 34530829 | PubTator, text mining | PubMed |
| Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods. | Front Oncol | 2021 | 34527588 | PubTator, text mining | PubMed |
| Neurotoxicity of a pyrethroid pesticide deltamethrin is associated with the imbalance in proteolytic systems caused by mitophagy activation and proteasome inhibition. | Toxicol Appl Pharmacol | 2021 | 34520793 | PubTator, text mining | PubMed |
| A nine-hub-gene signature of metabolic syndrome identified using machine learning algorithms and integrated bioinformatics. | Bioengineered | 2021 | 34516309 | PubTator, text mining | PubMed |
| Identification of CDC20 as a Novel Biomarker in Diagnosis and Treatment of Wilms Tumor. | Front Pediatr | 2021 | 34513754 | PubTator, text mining | PubMed |
| The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung. | J Oncol | 2021 | 34504528 | PubTator, text mining | PubMed |
| Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis. | Bioengineered | 2021 | 34499007 | PubTator, text mining | PubMed |
| Gene Expression Analysis Reveals Key Genes and Signalings Associated with the Prognosis of Prostate Cancer. | Comput Math Methods Med | 2021 | 34497666 | PubTator, text mining | PubMed |
| A single-cell and spatially resolved atlas of human breast cancers. | Nat Genet | 2021 | 34493872 | PubTator, text mining | PubMed |
| Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma. | Aging (Albany NY) | 2021 | 34493692 | PubTator, text mining | PubMed |
| Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC. | Aging (Albany NY) | 2021 | 34491228 | PubTator, text mining | PubMed |
| Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis. | BMC Cancer | 2021 | 34488675 | PubTator, text mining | PubMed |
| Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients. | Bioengineered | 2021 | 34488541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=39